The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 14 2026 for Ravi Agrawal trustee Ravi Agrawal Trust
14-Aug-2026
Download PDF
Ajanta Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 14 2026 for Ravi Agrawal trustee Ravi Agrawal Trust